White Paper: Real-world evidence without borders – Navigating evidence transportability in HTA and JCA decision-making

DOWNLOAD THE WHITE PAPER NOW!

Real-world evidence without borders: Navigating evidence transportability in HTA and JCA decision-making

Real-world evidence (RWE) is playing an increasingly vital role in health technology assessment (HTA), the EU Joint Clinical Assessment (JCA), and payer decision-making worldwide. A key challenge emerging is how to use evidence generated in one jurisdiction to inform decisions in another—a concept known as evidence transportability. As pharmaceutical manufacturers seek efficient, evidence generation solutions that overcome limitations of data sources in the target jurisdiction without costly duplication of studies across regions, evidence transportability is gaining traction as a pragmatic approach.

Download this white paper to explore the growing need for evidence transportability, common use cases, the challenges in applying non-local data, and learn more about our structured framework to assess and enable evidence transportability effectively.

Published as part of the Evidence Insights, "Beyond borders: the evolving role of evidence transportability", sponsored by Lumanity.